e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Monitoring acute respiratory failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Surfactant therapy - the real chance to survive for the patients with severe inhalation injury
M. Tarasenko, I. Shpakov, D. Kallistovl, I. Venevitinov, E. Akulinov, A. Tikhonov, A. Admakin, S. Petrachkov, A. Bautin, O. Rosenberg (St Petersburg, Russia)
Source:
Annual Congress 2004 - Monitoring acute respiratory failure
Session:
Monitoring acute respiratory failure
Session type:
Poster Discussion
Number:
4127
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Tarasenko, I. Shpakov, D. Kallistovl, I. Venevitinov, E. Akulinov, A. Tikhonov, A. Admakin, S. Petrachkov, A. Bautin, O. Rosenberg (St Petersburg, Russia). Surfactant therapy - the real chance to survive for the patients with severe inhalation injury. Eur Respir J 2004; 24: Suppl. 48, 4127
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Risk factors associated with the development of interstitial lung abnormalities
Indications and pitfalls of high-flow nasal cannula (HFNC) outside the intensive care unit
Related content which might interest you:
Efficacy of surfactant-BL in treatment ARDS in patients with severe inhalation injury
Source: Eur Respir J 2006; 28: Suppl. 50, 345s
Year: 2006
When to start surfactant therapy (ST-therapy) of acute lung injury?
Source: Eur Respir J 2001; 18: Suppl. 33, 7s
Year: 2001
Exogenous surfactant administration in patients at high risk to develop ARDS after multiple trauma
Source: Eur Respir J 2001; 18: Suppl. 33, 7s
Year: 2001
Surfactant treatment leads to a sustained improvement of oxygenation only in severe pediatric ARDS without pneumonia
Source: Eur Respir J 2001; 18: Suppl. 33, 318s
Year: 2001
Which severe COVID-19 patients may benefit the most from pulmonary rehabilitation?
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021
Importance of low-invasive monitoring for prevention of ARDS in patients with severe inhalation injury
Source: Annual Congress 2008 - Mechanical ventilation and airway management
Year: 2008
High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 140s
Year: 2003
Principles of surfactant-therapy ARDS in patients with severe inhalation trauma
Source: Annual Congress 2008 - Acute lung injury and weaning
Year: 2008
Is controlled oxygen therapy in COPD patients presenting in acute respiratory failure sub-optimal prior to commencement of NIV?
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Surfactant and inflammation in patients predisposed for ARDS after multiple trauma
Source: Annual Congress 2004 - The fourth ERS - free paper symposium on interdisciplinary basic and clinical surfactant research
Year: 2004
Contrivance - a major cause for failure of aerosol therapy in childhood
Source: Eur Respir J 2002; 20: Suppl. 38, 429s
Year: 2002
Critical illness polineuropathy as a cause of difficult weaning in stable patients with chronic respiratory failure: effect of rehabilitation
Source: Eur Respir J 2002; 20: Suppl. 38, 265s
Year: 2002
Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD
Source: Eur Respir J 2016; 47: 651-654
Year: 2016
Predictors of survival in severe COPD patients initiated on chronic NIV
Source: International Congress 2016 – New horizons for noninvasive ventilation in acute and chronic settings
Year: 2016
Is it effective to administer corticosteroids late for neonatal chronic lung disease?
Source: Eur Respir J 2004; 24: Suppl. 48, 620s
Year: 2004
Development of inhalation therapy for prevention and treatment of acute lung injury
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
Acute lung injury caused by toxic gas inhalation: a work injury case
Source: Annual Congress 2009 - Occupational exposures and disease I
Year: 2009
What the pulmonary specialist should know about the new inhalation therapies
Source: Eur Respir J 2011; 37: 1308-1417
Year: 2011
Short versus prolonged low dose steroid therapy early in the course of acute lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 263s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept